Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5443_Библиотеки_им_академика_М_И_Перельмана
.pdf
17.13.2 Cytotoxic effects
The discharged payload causes lethal effects within the cancer cell by interfering with
vital biological functions like microtubule formation and DNA replication. The pri-
mary characteristic that sets ADCs apart from conventional chemotherapy is their fo-
cused cytotoxicity.
17.13.3 Apoptosis induction
The cytotoxic payload frequently triggers apoptosis, a method of planned cell death.
By doing this, the cancer cell’s death process is regulated and well-organized, reduc-
ing the likelihood of unintentional harm to the nearby healthy tissues [82].
17.13.4 Selective action
Crucially, the mAb’s tailored delivery allows the cytotoxic payload to function just in-
side the cancer cell. ADCs are known for their selectivity, which helps to explain why
their systemic toxicity is lower.
17.13.5 Importance of linker design
Central to the success of ADCs is the careful design of the linker connecting the mAb
to the cytotoxic payload. The linker plays a piv otal role in ensuring stability during
circulation and enabling controlled payload release [83].
The linker must maintain stability during circulation, preventing premature pay-
load release. This stability is crucial for preserving the integrity of the ADC during its
journey to the target site.
17.13.6 Cleavability
Simultaneously, the linker must be designed to respond to specific intracellular condi-
tions, ensuring controlled and efficient payload release within the target cancer cell
[84]. The balance between stability and cleavability is a critical consideration in linker
design.
17 Molecular simulation-based technology for antibody–drug conjugates 403
https://t.me/med1917
17.13.7 Therapeutic impact
The combined action of target-specific binding and intracellular payload release en-
hances the therapeutic efficacy of ADCs. This targeted approach maximizes the impact
of the cytotoxic payload on cancer cells while minimizing its effects on healthy
tissues.
17.13.8 Reduced side effects
By selectively targeting cancer cells, ADCs minimize damage to healthy tissues, reduc-
ing the systemic toxicity associated with traditional chemotherapy. This reduction in
side effects contributes to the improved safety profile of ADCs.
17.14 Clinical success stories
Numerous ADCs have shown clinical efficacy and received regulatory approval. Ex-
amples are trastuzumab emtansine for HER2-positive breast cancer and benuximab
vedotin for Hodgkin’ s lymphoma. These achiev ements demonstrate the therapeutic
potential of ADCs for a variety of cancer types [85].
17.15 Significance in cancer treatment
Precision targeting: ADCs provide precision targeting by concentrating their cyto-
toxic payloads on cancer c ells while causing the least amount of harm to healthy
tissues.
Enhanced therapeutic index: By reducing systemic toxicity and maximizing thera-
peutic efficacy, the focused strategy produces an enhanced therapeutic index.
Overcoming drug resistance: By delivering cytotoxic medications directly to cancer
cells, ADCs offer a revolutionary approach to combat drug resistance [86].
17.16 Current state of ADC development
In recent years, the field of ADCs has undergone substantial growth and advancement,
with more than thirty new ADCs stepping into clinical development since 2013. Cur-
rently, the US FDA has granted full approval to nine ADCs [87]. Among these are gemtu-
404 Abhishek Singh et al.
https://t.me/med1917
zumab ozogamicin, brentuximab vedotin, and trastuzumab emtansine. Each of these
ADCs has its own set of mechanisms of action, indications, and clinical consequences.
Currently, the US FDA has granted full approval to nine ADCs. Among these are
gemtuzumab ozogamicin, brentuximab vedotin, and trastuzumab emtansine. Each of
these ADCs has its own set of mechanisms of action, uses, and clinical outcomes [88].
17.16.1 Gemtuzumab ozogamicin
Gemtuzumab ozogamicin, sometimes known as Mylotarg, is made out of a humanized
IgG4 mAb, conjugated with a calicheamicin payload, which targets the CD33 surface
antigen, which is seen in 85–90% of people with acute myeloid leukaemia.[3]
Mechanism of action: It is a CD33-targeted ADC that delivers a cytotoxic payload, tar-
geting cancer cells that express the CD33 antigen.
Specific indications: It was first permitted to treat relapsed or otherwise refractory
acute myeloid leukemia (R/R AML).
Clinical outcomes: Despite being approved initially, gemtuzumab ozogamicin was
shortly afterward pulled from the market due to unfavorable side effects.[4]
ADC Mechanism of
action
Targeted
indications
Clinical outcomes Limitations References
Brentuximab
vedotin
(Adcetris)
Binds to CD,
transports
monomethyl
auristatin-E
(MMAE), and
induces
apoptosis
Systemic
anaplastic
large cell
lymphoma and
Hodgkin
lymphoma
Long-lasting
responses in
patients with
recurring or
refractory Hodgkin
lymphoma and
effective
in anaplastic large
cell lymphoma
Peripheral
neuropathy,
neutropenia
symptoms, and
possibility of
resistance
[]
Ado-
trastuzumab
emtansine
(Kadcyla)
When
trastuzumab is
combined with
DM,it
suppresses
microtubule
assembly
HER-positive
breast cancer
Improved
progression-free
survival in patients
with HER-positive
metastatic breast
cancer who had
previously received
trastuzumab and a
taxane
Hepatotoxicity,
thrombocytopenia,
and possibility of
cardiotoxicity
[]
17 Molecular simulation-based technology for antibody–drug conjugates 405
https://t.me/med1917
(continued)
ADC Mechanism of
action
Targeted
indications
Clinical outcomes Limitations References
Tisotumab
vedotin-tftv
(Tivdak)
MMAE and
anti-tissue
factor antibody
are combined
Recurring or
metastatic
cervical
cancers
Promising results
in recurring or
metastatic cervical
cancer, significantly
better response
rates and durability
of treatment
Hemorrhagic
episodes, infusion-
related reactions,
and the possibility
of
myelosuppression
[]
Enfortumab
vedotin
(Padcev)
Targets
Nectin-,
releases MMAE,
and destroys
microtubules
Urothelial
cancer, either
locally
progressed or
metastatic
Improved rates of
recovery and
survival rates in
patients having
metastatic or
locally advanced
urothelial
carcinoma
Peripheral
neuropathy,
myelosuppression,
or the possibility of
infusion-related
complications
[]
Inotuzumab
ozogamicin
(Besponsa)
Binds to CD,
transports
calicheamicin,
and causes DNA
damage
Acute
lymphoblastic
leukemia with
relapsed or
persistent B-
cell precursors
Patients with
relapsed or
persistent B-cell
precursor acute
lymphoblastic
leukaemia had
higher percentages
of full remission
and overall survival
Hepatotoxicity,
infusion-related
responses, and the
risk of veno-
occlusive disease
are potential side
effects
[]
Trastuzumab
deruxtecan
(Enhertu)
Combines
trastuzumab
with a
topoisomerase I
inhibitor
Trastuzumab is
used in
combination
with a
topoisomerase
I inhibitor
HER-positive
breast cancer
Impressive results
in HER-positive
breast cancer
patients who had
been highly
pretreated, with
high response
rates and extended
progression-free
survival
[]
406 Abhishek Singh et al.
https://t.me/med1917
17.17 Role of molecular simulations in ADC
development
Molecular simulations have become indispensable tools in the field of molecular biol-
ogy, chemistry, and material science, providing a virtual lens to investigate the behav-
ior of molecules at an atomic and molecular level. Two prominent techniques, MD
simulations and MC simulations, play pivotal roles in unraveling the complexities of
molecular systems [89].
(continued)
ADC Mechanism of
action
Targeted
indications
Clinical outcomes Limitations References
Polatuzumab
vedotin-piiq
(Polivy)
Targets CDb,
releases MMAE,
and triggers cell
cycle arrest
Diffuse large B-
cell lymphoma
When administered
in conjunction with
other medicines, it
enhanced response
rates and
progression-free
survival in patients
with recurring or
refractory diffuse
large B-cell
lymphoma
Infusion reactions,
myelosuppression,
and the possibility
of peripheral
neuropathy
[]
Gemtuzumab
ozogamicin
(Mylotarg)
Binds to CD,
transports
calicheamicin,
and causes DNA
damage
Acute myeloid
leukemia
Improved survival
rates in specific
acute myeloid
leukaemia patient
populations
Hepatotoxicity,
infusion-related
reactions, and the
risk of veno-
occlusive disease
are all possible side
effects
[]
Sacituzumab
govitecan
(Trodelvy)
Targets Trop-,
supplies SN-,
and causes DNA
damage
Metastatic
triple-negative
breast cancer
Significant efficacy
in the treatment of
metastatic triple-
negative breast
cancer, resulting in
higher response
rates with
progression-free
survival
Neutropenia,
diarrhea, and the
possibility of liver
damage
[]
17 Molecular simulation-based technology for antibody–drug conjugates 407
https://t.me/med1917
17.17.1 Molecular dynamics simulations
MD simulations have become a mainstay in computational chemistry and biophysics,
enabling scientists to investigate the microscopic dynamic behavior of molecules. With
its broad applicability in many scientific fields, this potent computational method sheds
light on the kinetics, thermodynamics, and structural dynamics of molecular systems:
– Force fields: Force fields are mathematical models that explain a system’spoten-
tial energy, depending on the locations of its atoms. These models are the founda-
tion of MD simulations. Terms for bond stretching, angle bending, and nonbonded
interactions like electrostatic and van der Waals interactions are all included in
force fields [90].
– Equations of motion: The dynamics of the simulated system are controlled by
Newton’s equations of motion. MD simulations follow the motions of atoms and
molecules throughout time by numerically solving these equations.
– Integration algorithms: Different integration techniques are used to propagate the
dynamics of the system forward in time, including the Verlet algorithm [91]. The ac-
curacy of the molecular motion simulation is guaranteed by these algorithms.
17.17.2 Ensemble sampling in molecular dynamics
– Canonical ensemble (NVT): mimics a set temperature (T), volume (V), and parti-
cle count (N). This ensemble is pertinent to the study of systems at constant
temperature.
– Isothermal–isobaric ensemble (NPT): Maintains a constant number of particles
(N), pressure (P), and temperature (T) [92]. NPT simulations are suitable for study-
ing systems under constant temperature and pressure.
– Microcanonical ensemble (NVE): Simulates a fixed number of particles (N), vol-
ume (V), and energy (E). NVE simulations are useful for studying isolated systems
without exchange of energy with the surroundings.
17.17.3 Applications of molecular dynamic simulations
– Protein dynamics: An essential tool for understanding the dynamic behavior of
proteins is the MD simulation. This covers studies on conformational alterations,
protein folding, and the dynamics of interactions between proteins and ligands.
– Material science: MD simulations aid in the comprehension of a material’s mo-
lecular characteristics. Using MD, scientists can investigate a material’s structural
transitions, thermal conductivity, and mechanical characteristics.
– Drug design: MD simulations help with logical drug design by modeling the in-
teractions between medications and target proteins [93]. These simulations shed
408 Abhishek Singh et al.
https://t.me/med1917
light on binding affinities, binding routes, and structural modifications brought
about by binding.
– Biomembrane dynamics: MD simulations are utilized for examining biological
membrane dynamics. This covers studies on the behavior of lipid bilayers, inter-
actions between proteins and membranes, and the passage of molecules through
membranes.
17.17.4 Challenges and advances
– Timescale limitations: The time scales at which MD simulations may be per-
formed are frequently limited, which makes it difficult to simulate uncommon oc-
currences or long-term phenomena. To overcome these constraints, parallel
computing and improved sampling strategies have been used.
– Accuracy of force fields: The quality of force fields affects the precision of MD
simulatio ns. Research efforts are still focused on creating more precise models
and optimizing force field characteristics [94].
– Integration with experiments: It is difficult to bridge the gap between MD simu-
lations and experimental data. The goal of advances in methods such as machine
learning and Markov state models is to improve the relationship between experi-
mental and simulated data.
17.17.5 Future directions
– Advancements in hardware: MD simulations are anticipated to get longer and
more comprehensive as high-performance computers and specialized technology,
including graphics processing units (GPUs), continue to evolve [95].
– Integration with experimental techniques: MD simulations and experimental
methods like X-ray crystallography and cryo-electron microscopy are expected to
work together more and more in the future to provide a more thorough under-
standing of molecular systems.
– Exploration of conformational landscapes: Improvements in sampling techni-
ques will make it easier to explore intricate conformational landscapes and re-
veal uncommon events and transitions that are essential to comprehending the
behavior of molecules.
To sum up, MD simulation is an effective computational tool that helps to understand
the dynamic complexities of molecular systems [96]. MD simulations continue to pro-
vide a substantial contribution to our understanding of basic biological and chemical
processes as technology and methodology develop, opening new avenues for advance-
ments in materials research, drug discovery, and other fields.
17 Molecular simulation-based technology for antibody–drug conjugates 409
https://t.me/med1917
17.18 Monte Carlo simulations: navigating
probabilistic landscapes in molecular
modeling
MC simulations are a probabilistic method used extensively to describe the behavior
of complex systems in computational chemistry, physics, and other scientific fields.
MD simulations offer important insights into equilibrium features, phase transitions,
and thermodynamic behavior. In contrast to MD simulations, which investigate dy-
namic trajectories, MC simulations concentrate on the statistical sampling of configu-
rations [97].
17.18.1 Fundamentals of Monte Carlo simulations
– Random sampling: Random sampling is the fundamental idea of MC simula-
tions. A sequence of random configurations are generated in MC simulations in
accordance with specified probability distributions, as opposed to observing the
dynamic evolution of a system.
– Statistical ensembles: The limitations of the system are defined by the statistical
ensembles under which MC simulations are run [98]. The canonical ensemble
(NVT), isothermal–isobaric ensemble (NPT), and grand canonical ensemble are
examples of common ensembles that can be used to explore various thermody-
namic situations.
– Acceptance–rejection mechanism: A probabilistic criterion determines whether
proposed motions in configuration space are approved or denied. Configurations
are sampled in a way that aligns with the intended statistical ensemble thanks to
this process [99].
17.18.2 Monte Carlo algorithms
– Metropolis algorithm: One of the fundamental MC algorithms is the Metropolis
algorithm. A random move in configuration space is proposed, its associated en-
ergy change is calculated, and a probability criterion is used to determine
whether to accept or reject the move.
– Gibbs sampling: When it is possible to divide the configuration space into
smaller subspaces, Gibbs sampling is utilized [100]. It entails holding the other
variables constant while sampling configurations in each subspace one after the
other.
– Importance sampling: By using a biased sampling strategy, the sample is di-
rected toward configuration space regions that have a greater influence on the
410 Abhishek Singh et al.
https://t.me/med1917
behavior of the system. The effectiveness of MC simulations is increased by im-
portance sampling, especially in complex systems.
17.18.3 Applications of Monte Carlo simulations
– Phase transitions: Phase transitions, such as those between solid and liquid, liq-
uid and gas, and magnetic phases, may be studied very well with MC simulations.
MC simulations are able to depict a system’s behavior during a transition by sam-
pling configurations [101].
– Equilibrium thermodynamics: Temperature, pressure, density, and other ther-
modynamic characteristics at equilibrium can all be accurately estimated using
MC simulations. Systems at various phases of their phase diagrams can be studied
with great benefit from these simulations.
– Polymer conformations: MC simulations are used in polymer research to inves-
tigate the conformational space of polymer chains. This covers studies on the
structural transitions and statistical characteristics of polymers [102].
– Lattice models: In order to explore lattice models, in which particles occupy dis-
tinct places on a lattice, MC simulations are frequently employed. This method
works with a variety of systems, such as lattice gasses, magnetic materials, and
folding proteins.
17.18.4 Challenges and advances
– Convergence issues: In MC simulations, convergence can be difficult to achieve,
particularly for systems with intricate energy maps [103]. Convergence problems
are addressed by sophisticated algorithms and improved sampling techniques.
– High-dimensional spaces: It can be computationally costly to explore configura-
tion spaces with high dimensions. Improvements in optimization methods and
parallel computing capabilities enable more effective sampling in these do-
mains [104].
– Quantum MC: The study of electronic structure and quantum phenomena is
made possible by quantum MC methods, which apply the concepts of MC simula-
tions to quantum systems. These techniques provide a link between simulations
that are quantum and classical [105].
17.18.5 Future directions
– Machine learning integration: An emerging approach is the use of machine
learning methods with MC simulations. This entails utilizing machine learning
17 Molecular simulation-based technology for antibody–drug conjugates 411
https://t.me/med1917
models to speed up simulations, increase the precision of potential energy surfa-
ces, and improve sampling procedures.
– Quantum computing: MC simulations could undergo a significant transformation
with the introduction of quantum computing, especially when it comes to resolving
issues that are computationally unsolvable for conventional computers [106]. On
quantum computers, approaches for quantum MC are being investigated.
– Multiscale modeling: Multiscale modeling is made possible by combining MC
simulations with additional computing methods like quantum mechanics or MD
simulations. Researchers can investigate events over a variety of length and time
periods using this method [107].
MC researchers can examine the statistical behavior of complex systems using a prob-
abilistic lens thanks to MC simulations. MC simulations remain a flexible and potent
tool in computational science, providing important insights into the probabilistic na-
ture of molecular systems, from comprehending phase transitions to exploring the
equilibrium thermodynamics of materials [108]. MC simulations are at the forefront
of computer research thanks to advancements in algorithms, convergence methodolo-
gies, and integration with emerging technology.
17.19 Applications of molecular simulations
in ADC research
Molecular simulations have proven to be extremely useful in the field of research on
ADCs, offering in-depth understanding of crucial facets of their behavior. Here, we
explore particular uses for molecular simulations, illuminating the ways in which
these computational methods aid in the prediction of antibody–antigen interactions,
the investigation of payload-release mechanisms, and the comprehension of ADC sta-
bility and pharmacokinetics [109].
17.19.1 Predicting antibody–antigen interactions
MD simulations play a pivotal role in understanding and predicting the interactions
between antibodies and antigens in ADCs.
An essential component of ADC effectiveness is the contact between the antibody
and the antigen, and molecular simulations, namely MD, offer a virtual platform to
anticipate and enhance this interaction [110].
– Dynamic binding affinities: The investigation of dynamic antibody–antigen in-
teractions is made possible by MD simulations [111]. Researchers can estimate
binding affinities and identify minute conformational changes in the antibody
412 Abhishek Singh et al.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана